companydata.dkcompanydata.dk

Fortrea Denmark ApS: Financial statements 2023

CVR: 35240446

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

Fortrea Denmark ApS (CVR 35240446) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 37,846,930 and a net result of DKK 1,637,713 compared with DKK 3,183,261 the year before. That is a decrease of 7.6% compared with the year before. Equity in the 2023 report amounted to DKK 7,758,679. The solvency ratio was 55.3%. The company had 41 employees in the financial year.

Gross Profit
DKK 37,846,930
Profit/Loss
DKK 1,637,713
Equity
DKK 7,758,679
Total Assets
DKK 14,029,377
Employees
41

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-37.8 mio.1.6 mio.7.8 mio.41
2022-40.9 mio.3.2 mio.6.1 mio.41
2021-38.9 mio.2.7 mio.2.9 mio.43
2020-40.4 mio.3 mio.10.7 mio.46
2019-35.9 mio.2.5 mio.7.7 mio.43

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Amedeo Joseph De Risi joins Fortrea Denmark ApS as directorJun 22, 2023

As of June 22, 2023, Amedeo Joseph De Risi is registered as director of Fortrea Denmark ApS.

Robert Stewart Pringle steps down as director of Fortrea Denmark ApSJun 22, 2023

As of June 22, 2023, Robert Stewart Pringle has stepped down as director of Fortrea Denmark ApS.

Fortrea Denmark ApS: The 2022 annual report is outJun 7, 2023

Fortrea Denmark ApS has published its annual report for 2022. Gross profit came to DKK 40,948,646, and the net result was DKK 3,183,261.

Labcorp Clinical Development ApS changes name to Fortrea Denmark ApSMay 1, 2023

On May 1, 2023, the company changed its name from Labcorp Clinical Development ApS to Fortrea Denmark ApS.

About Fortrea Denmark ApS

Fortrea Denmark ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2013. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Labcorp Clinical Development ApS and COVANCE DENMARK ApS. The management consists of Agnieszka Moskal Gallagher. The company is owned by Fortrea Development Ltd.. The company has 31 employees (2026). In 2025, the company reported a gross profit of DKK 29,191,545 and a net result of DKK 1,739,960 compared with DKK 688,702 the year before. Equity in the 2025 report amounted to DKK 10,187,341.

Source: annual report 2025, Danish Business Authority